Key Lessons from the IDEA-FAST Final Conference
After seven years of collaboration, innovation, and scientific discovery, the IDEA-FAST project came to a successful close with its Final Conference on Wednesday, 17 June 2026. Held in Hamburg and online, the event brought together more than 150 participants from across Europe and beyond, including consortium members, external partners, researchers, clinicians, patients, and other stakeholders. […]
IDEA-FAST Final Conference
After seven years of collaboration, innovation, and scientific discovery, the IDEA-FAST project came to a successful close with its Final Conference on Wednesday, 17 June 2026. Held in Hamburg and online, the event brought together more than 150 participants from across Europe and beyond, including consortium members, external partners, researchers, clinicians, patients, and other stakeholders. […]
IDEA-FAST Guidelines for Patient-centered Remote Monitoring in Studies
The IDEA-FAST Guidelines for Patient-centred Remote Monitoring in Studies are now available! These guidelines are intended to support the design of a patient-centred Remote Monitoring Study. They are based on the insights and lessons learned from the IDEA-FAST project and the outcome of discussions during a Workshop on Remote Monitoring and Participant Involvement, organised as […]
IDEA-FAST Clinical Study Protocol Now Published!
Milestone Announcement: The IDEA-FAST consortium has published its major Clinical Study Protocol in DIGITAL HEALTH! This is one of the project’s most important publications to date! This paper outlines the IDEA-FAST Clinical Observational Study (COS). The IDEA-FAST COS, building on a preceding Feasibility Study and qualification advice of the European Medicines Agency, investigates the relationship between digital […]
IDEA-FAST Final Conference
Join us at the IDEA-FAST Final Conference, taking place on Wednesday, 17 June 2026, in Hamburg and online. The IDEA-FAST project is an IMI2 initiative launched in November 2019, bringing together 48 partners across 15 countries. Funded under the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement No. 853981), it aims to develop digital endpoints […]
The IDEA-FAST Clinical Observation Study Has Ended!
On 31 January 2026, the final IDEA-FAST Clinical Observation Study participant completed their last visit, marking the official end of our COS, with a total of 1,887 participants across all study sites. IDEA-FAST marks one of the largest clinical wearable sensor studies worldwide specifically focused on validating digital endpoints across multiple chronic diseases. The sensor […]
Real World Stories – Andrés Hibjan
In this instalment of our Real-World Series, we had a talk with Andrés Hibjan, an active member of Asociación Parkinson Madrid. As an engineer and adventurer, he treats his Parkinson’s diagnosis as a lifetime journey to an unknown destination. Using his technical knowledge, he tries to track and research his symptoms to improve his own […]
Real World Stories – Dina de Sousa
In this installment of the Real-World Series, we have a chat with Dina de Sousa, a member of the IDEA-FAST Advisory Board. Dina, an HD family member and a patient advocate for many years, has been involved in the project for a long time. She has been a board member of the European Huntington’s Association […]
IDEA-FAST 2025 Year-in-Review
As 2025 draws to a close, we would like to extend our heartfelt gratitude to all our consortium members, partners, and supporters. This has been a year full of challenges, but also many successes for our project. You can check out our 2025 Year-in-Review, an overview of our most important achievements of the year. We […]
IDEA-FAST COS Recruitment is Complete!
November 27, 2025 Major IDEA-FAST Milestone Achieved! Recruitment for the Clinical Observational Study (COS) is now complete, reaching 1891 participants across 20 sites in 10 European countries. This marks a major step towards identifying digital biomarkers that can transform how we measure fatigue and sleep disturbances — moving from subjective questionnaires to continuous, real-world digital […]